A Research Agenda for Malaria Eradication: Modeling
Malaria modeling can inform policy and guide research for malaria elimination and eradication from local implementation to global policy. A research and development agenda for malaria modeling is proposed, to support operations and to enhance the broader eradication research agenda. Models are envisioned as an integral part of research, planning, and evaluation, and modelers should ideally be integrated into multidisciplinary teams to update the models iteratively, communicate their appropriate use, and serve the needs of other research scientists, public health specialists, and government officials. A competitive and collaborative framework will result in policy recommendations from multiple, independently derived models and model systems that share harmonized databases. As planned, modeling results will be produced in five priority areas: (1) strategic planning to determine where and when resources should be optimally allocated to achieve eradication; (2) management plans to minimize the evolution of drug and pesticide resistance; (3) impact assessments of new and needed tools to interrupt transmission; (4) technical feasibility assessments to determine appropriate combinations of tools, an associated set of target intervention coverage levels, and the expected timelines for achieving a set of goals in different socio-ecological settings and different health systems; and (5) operational feasibility assessments to weigh the economic costs, capital investments, and human resource capacities required.
Vyšlo v časopise:
A Research Agenda for Malaria Eradication: Modeling. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000403
Kategorie:
Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000403
Souhrn
Malaria modeling can inform policy and guide research for malaria elimination and eradication from local implementation to global policy. A research and development agenda for malaria modeling is proposed, to support operations and to enhance the broader eradication research agenda. Models are envisioned as an integral part of research, planning, and evaluation, and modelers should ideally be integrated into multidisciplinary teams to update the models iteratively, communicate their appropriate use, and serve the needs of other research scientists, public health specialists, and government officials. A competitive and collaborative framework will result in policy recommendations from multiple, independently derived models and model systems that share harmonized databases. As planned, modeling results will be produced in five priority areas: (1) strategic planning to determine where and when resources should be optimally allocated to achieve eradication; (2) management plans to minimize the evolution of drug and pesticide resistance; (3) impact assessments of new and needed tools to interrupt transmission; (4) technical feasibility assessments to determine appropriate combinations of tools, an associated set of target intervention coverage levels, and the expected timelines for achieving a set of goals in different socio-ecological settings and different health systems; and (5) operational feasibility assessments to weigh the economic costs, capital investments, and human resource capacities required.
Zdroje
1. RossR
1908 Report on the prevention of malaria in Mauritius. London Waterlow and Sons Limited
2. MacdonaldG
1957 The epidemiology and control of malaria. London; New York Oxford University Press 201
3. WHO 1957 Expert Committee on Malaria, sixth report. Geneva World Health Organization
4. MacdonaldG
1956 Theory of the eradication of malaria. Bull World Health Organ 15 369 387
5. MacdonaldG
1956 Epidemiological basis of malaria control. Bull World Health Organ 15 613 626
6. DietzK
MolineauxL
ThomasA
1974 A malaria model tested in the African savannah. Bull World Health Organ 50 347 357
7. Garrett-JonesC
1964 Prognosis for interruption of malaria transmission through assessment of the mosquito's vectorial capacity. Nature 204 1173 1175
8. Garrett-JonesC
1964 The human blood index of malaria vectors in relation to epidemiological assessment. Bull World Health Organ 30 241 261
9. Diseases EAIoV-B 1960 Report on the Pare-Taveta Malaria Scheme, 1954-59. Dar es Salaam East Africa High Commission
10. Garrett-JonesC
GramicciaG
1954 Evidence of the development of resistance to DDT by Anopheles sacharovi in the Levant. Bull World Health Organ 11 865 883
11. GramicciaG
BealesPF
1988 The recent history of malaria control and eradication.
WernsdorferW
McGregorI
Principles and practice of malaria Edinburgh Churchill Livingstone 1335 1378
12. WHO 1974 Malaria control in countries where time-limited eradication is impracticable at present. Report of a WHO interregional conference Geneva World Health Organization
13. NajeraJ
1999 Malaria control: Achievements, problems, and strategies. Geneva WHO
14. The malERA Consultative Group on Monitoring, Evaluation, and Surveillance 2011 A research agenda for malaria eradication: Monitoring, evaluation and surveillance. PLoS Med doi:10.1371/journal.pmed.1000400 e1000400
15. The malERA Consultative Group on Basic Science and Enabling Technologies 2011 A research agenda for malaria eradication: Basic science and enabling technologies. PLoS Med doi:10.371/journal.pmed.1000399 e1000399
16. The malERA Consultative Group on Vector Control 2011 A research agenda for malaria eradication: Vector control. PLoS Med doi:10.1371/journal.pmed.1000401 e1000401
17. The malERA Consultative Group on Health Systems and Operational Research 2011 A research agenda for malaria eradication: Health systems and operational research. PLoS Med doi:10.1371/journal.pmed.1000397 e1000397
18. The malERA Consultative Group on Vaccines 2011 A research agenda for malaria eradication: Vaccines. PLoS Med doi:10.1371/journal.pmed.1000398 e1000398
19. The malERA Consultative Group on Drugs 2011 A research agenda for malaria eradication: Drugs. PLoS Med doi:10.1371/journal.pmed.1000402 e1000402
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 1
- Statinová intolerance
- Monoklonální protilátky v léčbě hyperlipidemií
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Význam hydratace při hojení ran
Najčítanejšie v tomto čísle
- A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
- Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa
- The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study